The ScoreEconomic PulseMillion BazillionI've Always Wondered ...Make Me Smart Daily

Loading...

0:00
0% played
Stories Tagged as

COVID-19 vaccine

COVID-19

At this point in the pandemic, will there be a market for the Novavax vaccine?

by Kristin Schwab
Jun 8, 2022
The anti-COVID shot passes muster with FDA advisers. It was developed with traditional technology, which might boost trust.
Experts recommended that the FDA approve Novavax's new COVID vaccine, which was created with more traditional technology than the methods used by Pfizer and Moderna.
Carsten Koall/Getty Images
ListenLISTEN
HTML EMBED:
COPY
EMBED EMBED
Share Now on:
SHARE
Subscribe Using:
SUBSCRIBE SUBSCRIBE
COVID-19

A New Jersey community pharmacy's vaccine rollout, a year later

by Marielle Segarra
Mar 1, 2022
This time last year, Bell Pharmacy was doing everything it could to prepare for COVID-19 vaccines ... without knowing when the doses would arrive.
Tony Minniti, owner of Bell Pharmacy, worked with community groups to bring the vaccine to local residents.
Courtesy Minniti
ListenLISTEN
HTML EMBED:
COPY
EMBED EMBED
Share Now on:
SHARE
Subscribe Using:
SUBSCRIBE SUBSCRIBE
COVID-19

WHO plan will help ramp up COVID vaccine production in Africa

by Lily Jamali
Feb 18, 2022
Egypt, Kenya, Nigeria, Senegal, South Africa and Tunisia will have access to mRNA vaccine technology. Is that enough?
While global vaccination rates hover at around 60%, vaccine rates in Africa are just a fraction of that.
Jonathan Nackstrand/ AFP Getty Images
ListenLISTEN
HTML EMBED:
COPY
EMBED EMBED
Share Now on:
SHARE
Subscribe Using:
SUBSCRIBE SUBSCRIBE

COVID-19 vaccine for kids under 5 could be available soon

by Amanda Peacher
Feb 2, 2022
As the number of vaccinated people increases, so does movement in the economy.
ROBYN BECK/AFP via Getty Images
ListenLISTEN
HTML EMBED:
COPY
EMBED EMBED
Share Now on:
SHARE
Subscribe Using:
SUBSCRIBE SUBSCRIBE
COVID-19

Investors pressure Moderna to broaden global access to vaccine

by Lily Jamali
Dec 28, 2021
The company is under scrutiny over vaccine equity. It received considerable U.S. government help in developing its vaccine.
As the omicron variant spreads, some shareholders of Moderna are criticizing the company, arguing its price for the COVID-19 vaccine is too high for low-income countries.
Angela Weiss/AFP via Getty Images
ListenLISTEN
HTML EMBED:
COPY
EMBED EMBED
Share Now on:
SHARE
Subscribe Using:
SUBSCRIBE SUBSCRIBE
COVID-19

Biden pressed to support intellectual property waiver for COVID-19 vaccines

by Lily Jamali
Nov 26, 2021
Advocates say a waiver is "a moral imperative" to help make vaccines readily available worldwide.
In a letter, more than 15 countries called an emergency intellectual property waiver for COVID vaccines “a moral imperative."
Patrick T. Fallon/AFP via Getty Images
ListenLISTEN
HTML EMBED:
COPY
EMBED EMBED
Share Now on:
SHARE
Subscribe Using:
SUBSCRIBE SUBSCRIBE

Canadians factor COVID testing costs into shopping trips across U.S. border

by Lily Jamali
Nov 19, 2021
The border is now open to vaccinated Canadians, but their government compels citizens to show a negative test to get back home.
Travelers on the U.S. side wait to cross into Canada at Niagara Falls, Ontario. Canadians can now cross into the U.S. for nonessential travel but must have a pricey PCR test to return.
Geoff Robins/AFP via Getty Images
ListenLISTEN
HTML EMBED:
COPY
EMBED EMBED
Share Now on:
SHARE
Subscribe Using:
SUBSCRIBE SUBSCRIBE

For public good, not for profit.

Support fact-based, independent journalism with a gift to Marketplace today.

Invest in marketplace

Do COVID-19 vaccine incentives work?

by Caroline Champlin
Oct 26, 2021
New research suggests that offering people money as an incentive to get vaccinated may actually make some, who were already skeptical, more distrustful.
People march across the Brooklyn Bridge to protest the COVID-19 vaccine mandate for municipal workers on Oct. 25, 2021 in New York City.
David Dee Delgado/Getty Images
ListenLISTEN
HTML EMBED:
COPY
EMBED EMBED
Share Now on:
SHARE
Subscribe Using:
SUBSCRIBE SUBSCRIBE

Inside CureVac's odyssey to produce a COVID-19 vaccine

by Victoria Craig
Oct 1, 2021
CureVac finds itself playing catch-up with other companies in producing a COVID vaccine, but the company refuses to give up.
General view outside the company of German vaccine maker CureVac on September 1, 2020 in Tubingen, Germany.
Christian Kaspar-Bartke/Getty Images
ListenLISTEN
HTML EMBED:
COPY
EMBED EMBED
Share Now on:
SHARE
Subscribe Using:
SUBSCRIBE SUBSCRIBE
COVID-19

Banking on a vaccine-verification bonanza

by Kristin Schwab
Sep 30, 2021
Companies large and small are vying for a piece of what they believe will be a lucrative market for verifying shot status.
A Nitehawk Cinema worker checks for proof of COVID-19 vaccination on Sept. 8 in Brooklyn, New York.
Michael M. Santiago via Getty Images
ListenLISTEN
HTML EMBED:
COPY
EMBED EMBED
Share Now on:
SHARE
Subscribe Using:
SUBSCRIBE SUBSCRIBE